BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Drug Development

  Selumetinib Granted Orphan Drug Designation by the U.S. FDA for Neurofibromatosis Type 1

  AstraZeneca and Merck announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for selumetinib, a MEK 1/2 inhibitor, for the treatment of neurofibromatosis type 1 (NF1).

  February 15, 2018

   · 

  7 min read
• 

  Business

  Oxford BioMedica Wins $105M Gene Therapy Contract From Bioverativ

  The deal includes a licence to use OXB’s LentiVector Enabled technology and access to its industrial-scale manufacturing technology.

  February 15, 2018

   · 

  3 min read
• Pharm Country

  Realm Therapeutics Highlights Strong 2017 Performance and Outlines 2018 Milestones

  Realm Therapeutics today provided a clinical and business update.

  February 15, 2018

   · 

  5 min read
• Spectrum Pharmaceuticals to Present Corporate Update at the 2018 RBC Capital Markets Global Healthcare Conference on February 22nd

  The Company presentation is on Thursday, February 22, 2018, at 10:30 AM ET.

  February 15, 2018

   · 

  3 min read
• Business

  Incyte Reports 2017 Fourth-Quarter and Year-End Financial Results, Provides 2018 Financial Guidance and Updates on Key Clinical Programs

  For the quarter ended December 31, 2017, total revenues were $444 million as compared to $326 million for the same period in 2016.

  February 15, 2018

   · 

  24 min read
• Biotech Bay

  Data from BioTime’s OpRegen and Vision Restoration Programs to Be Presented at ARVO 2018

  BioTime today announced that two abstracts have been accepted and will be presented at the upcoming Association for Research in Vision and Ophthalmology (ARVO) meeting taking place from April 29th – May 3rd, 2018, in Honolulu, Hawaii.

  February 15, 2018

   · 

  4 min read
• Business

  Zoetis Reports Fourth Quarter and Full Year 2017 Results

  The company reported revenue of $1.5 billion for the fourth quarter of 2017, which was an increase of 14% compared with the fourth quarter of 2016.

  February 15, 2018

   · 

  39 min read
• Biotech Beach

  MabVax Therapeutics Schedules Previously Announced 1-for-3 Reverse Stock Split to Regain Compliance with NASDAQ’s $1.00 Minimum Bid Price Maintenance Requirement

  There is no guarantee that the Company will successfully regain compliance.

  February 15, 2018

   · 

  6 min read
• Business

  Imprimis Pharma to Host its Fourth Quarter 2017 Financial Report Conference Call and Webcast on March 8, 2018 at 4:30 p.m. EST

  The company will host a conference call at 4:30 p.m. EST/1:30 p.m. PST on the same day to discuss the financial results and recent business developments.

  February 15, 2018

   · 

  3 min read
• Drug Development

  Arrowhead Receives Regulatory Clearance to Begin Phase I/II Study of ARO-HBV for Treatment of Hepatitis B

  The company anticipates that dosing will begin around the end of March.

  February 15, 2018

   · 

  3 min read